By Associate Professor Amany Zekry

Conference Papers

Palmer CS; Nguyen N; Lloyd AR; Zekry A, 2008, 'EFFECT OF STEATOSIS ON THE INTRAHEPATIC CYTOKINE/CHEMOKINE RESPONSES IN CHRONIC HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, CA, San Francisco, pp. 789A - 789A, presented at 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, CA, San Francisco, 31 October 2008 - 04 November 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259757401463&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Choo L; Morris DL; Chu F; Liauw WS; Zekry A, 2008, 'Clinical characteristics of patients with hepatocellular carcinoma presenting to a single tertiary institute', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A279 - A279, presented at Journal of Gastroenterology and Hepatology

Aggarwal V; Palmer C; Nguyen ND; Lloyd AR; Zekry A, 2008, 'Differential expression of interferon stimulating genes in obese subjects receiving treatment for chronic hepatitis C', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A282 - A282, presented at Journal of Gastroenterology and Hepatology, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100215&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Aggarwal V; Palmer C; Lloyd AR; Zekry A, 2008, 'EFFECT OF OBESITY ON INTERFERON STIMULATED GENES EXPRESSION IN CHRONIC HCV INFECTION', in Hepatology, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. 1248 - 1249, presented at Hepatology

Palmer C; Nguyen ND; Lloyd AR; Zekry A, 2008, 'Effect of obesity on the intrahepatic cytokine/chemokine responses in chronic hepatitis C', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A285 - A285, presented at Journal of Gastroenterology and Hepatology, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Palmer C; Nguyen ND; Lloyd AR; Zekry A, 2008, 'EFFECT OF STEATOSIS ON THE INTRAHEPATIC CYTOKINE/CHEMOKINE RESPONSES IN CHRONIC HCV', in Hepatology, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. 1080 - 1081, presented at Hepatology

Li SYW; Yan KK; Palmer C; Guirgis M; Bu Y; Zekry A, 2008, 'High retinol binding protein-4 and low adiponectin levels are associated with steatosis in bariatric patients', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A285 - A285, presented at Journal of Gastroenterology and Hepatology

Maher L; Dore G; Treloar C; Rawlinson W; White P; Dolan K; Zekry A; Madden A; Loveday S; Kaldor J; Lloyd A, 2008, 'Preparedness for candidate hepatitis C vaccine trials in people who inject drugs: challenges and opportunities', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A358 - A358

Aggarwal V; Jorgenson J; Talbot ML; Loi KW; Zekry A, 2008, 'Statins may aggravate liver injury in obese subjects with nonalcoholic fatty liver disease', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A283 - A283, presented at Journal of Gastroenterology and Hepatology, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100218&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Zekry A; Walley N; Weale M; Ginsburg G; Goldstein D; McHutchison JG, 2007, 'Polymorphisms in adrenergic receptors, adiponcetin and adiponectin receptors influence fibrosis rates and response to therapy in chronic HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 440A - 440A, presented at 58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 02 November 2007 - 06 November 2007, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249910400460&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Freeman AJ; Zekry A; Whybin LR; Harvey CE; van Beek IA; de Kantzow SL; Rawlinson WD; Boughton CR; Robertson PW; Marinos G, 2000, 'Hepatitis C Virus prevalence and genotype among Australian injecting drug users in the 1970s.', in HEPATOLOGY, W B SAUNDERS CO, pp. 279A - 279A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089622400468&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Williams RB; Zekry A; Cook IJ, 1999, 'The mechanisms of rumination and the role of lower esophageal sphincter (LES) relaxations.', in Gastroenterology, W B Saunders Co, Philadelphia, PA, USA, pp. A704 - A704, presented at Digestive Disease Week and the 99th Annual Meeting of the American Gastroenterological Association, New Orleans, Louisiana, USA, 17 May 1999 - 20 May 1999, http://dx.doi.org/10.1016/S0016-5085(98)82889-8

Conference Posters

Polis SJ; Paven G; Zekry A; Zhang L, 2014, 'Factors associated with medication adherence in patients living with cirrhosis', Boston, presented at American Association Society for Liver Disease (AASLD) Liver meeting, Boston, 07 November 2014 - 10 November 2014

Conference Abstracts

Roberts SK; Maharaj A; Lubel J; Lam E; Clark PJ; Duncan O; George J; Jeffrey GP; Lipton L; Liu H; McCaughan G; Neo E-L; Philip J; Strasser SI; Stuart K; Thompson A; Tibbals J; Tu T; Wallace MC; Wigg A; Wood M; Zekry A; Greenhill E; Ioannou LJ; Ahlenstiel G; Bowers K; Clarke SJ; Dev A; Goodwin M; Karapetis C; Levy MT; Muller K; O'Beirne JP; Pryor D; Seow J; Tallis CJ; Butler N; Olynyk JK; Zalcberg J, 2022, 'MONITORING QUALITY OF CARE IN HEPATOCELLULAR CARCINOMA: A MODIFIED DELPHI CONSENSUS', in HEPATOLOGY, WILEY, Vol. 76, pp. S1311 - S1312, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000870796604144&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shen SS; Jackson M; Khatiwada S; Vijayan A; Raposo A; El-Omar E; Behary J; Zekry A, 2022, 'EFFECT OF GUT INFLUENCE ON THE IMMUNE ENVIRONMENT IN PRE-CLINICAL HCC', in GUT, BMJ PUBLISHING GROUP, Vol. 71, pp. A5 - A5, http://dx.doi.org/10.1136/gutjnl-2022-IDDF.6

Behary J; Raposo A; Zheng H; Amorim N; Gong L; Mcgovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson M; Mccaughan G; El-Omar E; Zekry A, 2020, 'Defining the temporal evolution of the gut microbiome and associated intrahepatic immune response in the Mdr2-/- model of hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 19 - 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Behary J; Amorim N; Jiang X; Raposo A; Gong L; Mcgovern E; Chu F; Stephens C; Jebeili H; Fragomeli V; Koay YC; Jackson M; O'Sullivan J; Weltman M; Mccaughan G; El-Omar E; Zekry A, 2020, 'Impact of the gut microbiome and metabolome on the peripheral immune response in non-alcoholic fatty liver disease-related hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 19 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rees V; Behary J; Stephens C; Jebeili H; Szczesniak M; Zekry A; Freiman J, 2019, 'Alterations in metabolic risk factor profile in the transition from non-alcoholic fatty liver disease (NAFLD) to NAFLD-related hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 58 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zekry A; Rimassa L; Kelley R; Meyer T; Ryoo B; Merle P; Park J; Blanc J; Lim H; Tran A; Borgman-Hagey A; Clary D; Wang E; Cheng A; El-Khoueiry A; Abou-Alfa G, 2019, 'Outcomes based on plasma biomarkers for the Phase III CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 41 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kharbat M; Rolls S; Pavendranathan G; Choo L; Zekry A, 2019, 'Virtual clinic for positive fecal occult blood test result: Our local experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 238 - 238, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100377&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; Zekry A; George J; Maher L, 2016, 'Factors associated with adherence to hepatocellular carcinoma surveillance in patients undergoing hepatitis B anti-viral therapy in Australia.', in HEPATOLOGY, WILEY, MA, Boston, Vol. 64, pp. 811A - 811A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493804001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; Zekry A; George J; Maher L, 2016, 'Predictors of non-adherence to HBV anti-viral therapy', in HEPATOLOGY, WILEY, MA, Boston, Vol. 64, pp. 812A - 812A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493804004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Datasets

Polis S; Zhang L; Bhawana M; Pons R; Pavendranathan G; Zekry A; Fernandez R, 2016, Knowledge of Treatment and Disease Questionnaire, , http://dx.doi.org/10.1037/t51934-000

Preprints

Thilakanathan C; Zandavi SM; Kim C; Goodwin T; Akon AC; Majeed A; Kemp W; Chu F; Smith M; Jebeili H; Behary J; Roberts S; Vafee F; Zekry A, Artificial Intelligence Reliably Identifies Patients at Risk of HCC Recurrence 1-Year Post-Surgical Resection, , http://dx.doi.org/10.2139/ssrn.4006151

Back to profile page